Kraton Corp (KRA) Shares Sold by Hsbc Holdings PLC

Share on StockTwits

Hsbc Holdings PLC reduced its holdings in shares of Kraton Corp (NYSE:KRA) by 5.6% during the third quarter, HoldingsChannel reports. The firm owned 123,994 shares of the specialty chemicals company’s stock after selling 7,328 shares during the period. Hsbc Holdings PLC’s holdings in Kraton were worth $5,845,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also made changes to their positions in the company. BlackRock Inc. lifted its holdings in Kraton by 8.5% in the second quarter. BlackRock Inc. now owns 4,358,381 shares of the specialty chemicals company’s stock valued at $201,097,000 after acquiring an additional 341,081 shares during the period. Advisors Asset Management Inc. lifted its holdings in Kraton by 11,720.7% in the second quarter. Advisors Asset Management Inc. now owns 182,748 shares of the specialty chemicals company’s stock valued at $192,000 after acquiring an additional 181,202 shares during the period. Assenagon Asset Management S.A. lifted its holdings in Kraton by 665.4% in the third quarter. Assenagon Asset Management S.A. now owns 166,549 shares of the specialty chemicals company’s stock valued at $7,853,000 after acquiring an additional 144,788 shares during the period. Renaissance Technologies LLC lifted its holdings in Kraton by 17.0% in the second quarter. Renaissance Technologies LLC now owns 993,000 shares of the specialty chemicals company’s stock valued at $45,817,000 after acquiring an additional 144,000 shares during the period. Finally, American Century Companies Inc. lifted its holdings in Kraton by 47.4% in the second quarter. American Century Companies Inc. now owns 215,569 shares of the specialty chemicals company’s stock valued at $9,946,000 after acquiring an additional 69,301 shares during the period. 96.11% of the stock is currently owned by hedge funds and other institutional investors.

KRA stock opened at $23.93 on Friday. Kraton Corp has a fifty-two week low of $23.48 and a fifty-two week high of $53.99. The company has a debt-to-equity ratio of 2.11, a quick ratio of 1.04 and a current ratio of 2.33. The stock has a market capitalization of $777.52 million, a price-to-earnings ratio of 7.72 and a beta of 1.74.

Kraton (NYSE:KRA) last posted its earnings results on Wednesday, October 24th. The specialty chemicals company reported $1.02 earnings per share for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.19). Kraton had a net margin of 5.87% and a return on equity of 14.83%. The firm had revenue of $523.11 million during the quarter, compared to the consensus estimate of $528.00 million. On average, equities analysts predict that Kraton Corp will post 3.16 earnings per share for the current year.

KRA has been the topic of a number of recent research reports. ValuEngine downgraded Kraton from a “buy” rating to a “hold” rating in a report on Monday, August 13th. Zacks Investment Research downgraded Kraton from a “hold” rating to a “sell” rating in a report on Thursday, October 18th. TheStreet downgraded Kraton from a “b-” rating to a “c+” rating in a report on Monday, November 12th. SunTrust Banks downgraded Kraton from a “buy” rating to a “hold” rating in a report on Friday, October 26th. Finally, Loop Capital set a $76.00 target price on Kraton and gave the company a “buy” rating in a report on Wednesday, August 15th. Three research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $57.50.

In other Kraton news, insider Stephen E. Tremblay sold 13,085 shares of the company’s stock in a transaction dated Thursday, September 20th. The stock was sold at an average price of $49.50, for a total value of $647,707.50. Following the completion of the sale, the insider now owns 102,409 shares in the company, valued at $5,069,245.50. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Kevin Michael Fogarty sold 27,748 shares of the company’s stock in a transaction dated Friday, September 21st. The stock was sold at an average price of $50.00, for a total value of $1,387,400.00. Following the completion of the sale, the chief executive officer now owns 273,281 shares of the company’s stock, valued at approximately $13,664,050. The disclosure for this sale can be found here. 4.71% of the stock is currently owned by corporate insiders.

WARNING: “Kraton Corp (KRA) Shares Sold by Hsbc Holdings PLC” was published by BBNS and is owned by of BBNS. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The original version of this news story can be accessed at https://baseballnewssource.com/2018/12/08/kraton-corp-kra-shares-sold-by-hsbc-holdings-plc/3064298.html.

About Kraton

Kraton Corporation manufactures and sells styrenic block copolymers and other engineered polymers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Polymer and Chemical. The Polymer segment offers performance products, including styrene-butadiene-styrene and styrene-isoprene-styrene; and specialty polymers, such as hydrogenated styrenic block copolymers, as well as isoprene rubber and isoprene rubber latex for use in medical and personal care products, adhesives, tackifiers, paints, and coatings.

See Also: Technical Analysis of Stocks and What It Means

Want to see what other hedge funds are holding KRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kraton Corp (NYSE:KRA).

Institutional Ownership by Quarter for Kraton (NYSE:KRA)

Receive News & Ratings for Kraton Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kraton and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.